Oral piritrexim--a phase II study in patients with advanced soft tissue sarcoma.
Schiesel
J D
JD
Synertron, Inc., Madison, WI.
Carabasi
M
M
Magill
G
G
Casper
E
E
Cheng
E
E
Marks
L
L
Feyzi
J
J
Clendeninn
N J
NJ
Smalley
R V
RV
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005260:Female; D005493:Folic Acid Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011743:Pyrimidines / Q000008:administration & dosage / Q000627:therapeutic use*; D012509:Sarcoma / Q000188:drug therapy* / Q000556:secondary; D012983:Soft Tissue Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
D005493:Folic Acid Antagonists; D011743:Pyrimidines; C024530:piritrexim